References
- HerrickLMSpaldingWMSaitoYAMoriartyJSchleckCA case–control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohortJ Med Econ201720327327927783533
- MartinBCBarghoutVCerulliADirect medical costs of constipation in the United StatesManag Care Interface200619124349
- SuaresNCFordACPrevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysisAm J Gastroenterol20111069158291 quiz 1581, 159221606976
- DiazSMendezMDConstipationTreasure Island (FL)StatPearls Publishing LLC2018
- FordACMoayyediPLacyBEAmerican College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipationAm J Gastroenterol2014109Suppl 1S2S26 quiz S2725091148
- JohansonJFKralsteinJChronic constipation: a survey of the patient perspectiveAliment Pharmacol Ther200725559960817305761
- TalleyNJWeaverALZinsmeisterARMeltonLJ3rdOnset and disappearance of gastrointestinal symptoms and functional gastrointestinal disordersAm J Epidemiol199213621651771415139
- LemboACamilleriMChronic constipationN Engl J Med2003349141360136814523145
- LawMFHoRCheungCKPrevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapyWorld J Gastroenterol201622286484650027605883
- LangLThe Food and Drug Administration approves lubiprostone for irritable bowel syndrome with constipationGastroenterology200813517
- LoombaRRowleyAWesleyRSystematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapyAnn Intern Med2008148751952818378948
- LacyBELevyLCLubiprostone: a chloride channel activatorJ Clin Gastroenterol200741434535117413599
- BarishCFDrossmanDJohansonJFUenoREfficacy and safety of lubiprostone in patients with chronic constipationDig Dis Sci20105541090109720012484
- JohansonJFUenoRLubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safetyAliment Pharmacol Ther200725111351136117509103
- JohansonJFMortonDGeenenJUenoRMulticenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipationAm J Gastroenterol2008103117017717916109
- FukudoSHongoMKanekoHTakanoMUenoRLubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipationClin Gastroenterol Hepatol2015132294301.e525158925
- FukudoSHongoMKanekoHUenoREfficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding studyNeurogastroenterol Motil2011236544e20521303430
- FordACSuaresNCEffect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysisGut201160220921821205879
- HuangHTaylorDCCarsonRTEconomic evaluation of linaclotide for the treatment of adult patients with chronic idiopathic constipation in the United StatesManag Care20162524148
- LiFFuTTongWDLubiprostone is effective in the treatment of chronic idiopathic constipation and irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trialsMayo Clin Proc201691445646827046523
- CryerBDrossmanDACheyWDWebsterLHabibiSWangMAnalysis of nausea in clinical studies of lubiprostone for the treatment of constipation disordersDig Dis Sci201762123568357828849329
- JohansonJFDrossmanDAPanasRWahleAUenoRClinical trial: Phase 2 study of lubiprostone for irritable bowel syndrome with constipationAliment Pharmacol Ther200827868569618248656
- DrossmanDACheyWDJohansonJFClinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome – results of two randomized, placebo-controlled studiesAliment Pharmacol Ther200929332934119006537
- PenningtonBMarriottERLichtlenPAkbarAHatswellAJThe cost effectiveness of lubiprostone in chronic idiopathic constipationPharmacoecon Open20182324125329302926